Severity and body surface area are used together to calculate something called a Psoriasis Area and Severity Index (PASI) score. It combines the severity and surface area for six regions of your body.

Further, 5 studies used ML to predict psoriasis severity based on Body Surface Area (BSA), with 1 artificial neural network model achieving an intraclass correlation coefficient of 0.96 (95% CI, 0 ...

People with psoriasis have an increased risk of developing psoriatic arthritis (PsA). New research shows that psoriasis severity and body surface area play a role in determining the extent of the ...

A new subgroup analysis reveals that adolescents with moderate-to-severe plaque psoriasis treated with once-daily icotrokinra ...

Discover a study that analysed evidence showing that metabolic disturbances can also exacerbate psoriasis symptoms. Learn ...

The Psoriasis Area Severity Index (PASI) is a scale for assessing and grading the severity of psoriasis and the response to treatment. The scale uses a score from 0–72.

In people with psoriasis, systemic inflammation may have an indirect but significant influence on the relationship between cardiovascular disease (CVD) risk and skin disease severity. A recent ...

Patients' acceptance of psoriasis depends on disease severity, itch intensity, and the patients' quality of life: A cross-sectional study. J Clin Med . 2024;13(24):7684. Published 2024 Dec 17. doi ...

Findings showed 64.7% of icotrokinra-treated patients achieved IGA scores 0/1 and 49.6% achieved PASI 90 compared with 8.3% and 4.4% of those on placebo, respectively. Topline results were ...

The PASI score grades the amount of surface area on each body region that is covered by psoriasis plaques and the severity of plaques for their redness, thickness and scaliness.3 PASI 90 ...

Body surface area (BSA) offers a standard, simple, and objective way to classify disease severity. The statement emphasizes treatment of high-impact limited disease at "special sites ...